Compare LITB & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LITB | ECOR |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.4M | 50.0M |
| IPO Year | 2013 | 2018 |
| Metric | LITB | ECOR |
|---|---|---|
| Price | $2.68 | $7.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | 8.0K | ★ 41.3K |
| Earning Date | 01-01-0001 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.51 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,182,000.00 |
| Revenue This Year | N/A | $28.92 |
| Revenue Next Year | N/A | $32.50 |
| P/E Ratio | $10.96 | ★ N/A |
| Revenue Growth | N/A | ★ 57.09 |
| 52 Week Low | $0.92 | $4.16 |
| 52 Week High | $4.17 | $16.18 |
| Indicator | LITB | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 46.62 | 65.52 |
| Support Level | $2.39 | $4.64 |
| Resistance Level | $2.98 | $8.10 |
| Average True Range (ATR) | 0.21 | 0.58 |
| MACD | -0.02 | 0.19 |
| Stochastic Oscillator | 13.46 | 93.05 |
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.